Cargando…
Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
Inter- and intra-fractional prostate motion can deteriorate the dose distribution in extremely hypofractionated intensity-modulated proton therapy. We used verification CTs and prostate motion data calculated from 1024 intra-fractional prostate motion records to develop a voxel-wise based 4-dimensio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407426/ https://www.ncbi.nlm.nih.gov/pubmed/37560512 http://dx.doi.org/10.1016/j.phro.2023.100474 |
_version_ | 1785085959203717120 |
---|---|
author | Feng, Sen-Quan Brouwer, Charlotte L. Korevaar, Erik W. Vapiwala, Neha Kang-Hsin Wang, Ken Deville, Curtiland Langendijk, Johannes A. Both, Stefan Aluwini, Shafak |
author_facet | Feng, Sen-Quan Brouwer, Charlotte L. Korevaar, Erik W. Vapiwala, Neha Kang-Hsin Wang, Ken Deville, Curtiland Langendijk, Johannes A. Both, Stefan Aluwini, Shafak |
author_sort | Feng, Sen-Quan |
collection | PubMed |
description | Inter- and intra-fractional prostate motion can deteriorate the dose distribution in extremely hypofractionated intensity-modulated proton therapy. We used verification CTs and prostate motion data calculated from 1024 intra-fractional prostate motion records to develop a voxel-wise based 4-dimensional method, which had a time resolution of 1 s, to assess the dose impact of prostate motion. An example of 100 fractional simulations revealed that motion had minimal impact on planning dose, the accumulated dose in 95 % of the scenarios fulfilled the clinical goals for target coverage (D95 > 37.5 Gy). This method can serve as a complementary measure in clinical setting to guarantee plan quality. |
format | Online Article Text |
id | pubmed-10407426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104074262023-08-09 Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer Feng, Sen-Quan Brouwer, Charlotte L. Korevaar, Erik W. Vapiwala, Neha Kang-Hsin Wang, Ken Deville, Curtiland Langendijk, Johannes A. Both, Stefan Aluwini, Shafak Phys Imaging Radiat Oncol Technical Note Inter- and intra-fractional prostate motion can deteriorate the dose distribution in extremely hypofractionated intensity-modulated proton therapy. We used verification CTs and prostate motion data calculated from 1024 intra-fractional prostate motion records to develop a voxel-wise based 4-dimensional method, which had a time resolution of 1 s, to assess the dose impact of prostate motion. An example of 100 fractional simulations revealed that motion had minimal impact on planning dose, the accumulated dose in 95 % of the scenarios fulfilled the clinical goals for target coverage (D95 > 37.5 Gy). This method can serve as a complementary measure in clinical setting to guarantee plan quality. Elsevier 2023-07-22 /pmc/articles/PMC10407426/ /pubmed/37560512 http://dx.doi.org/10.1016/j.phro.2023.100474 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Technical Note Feng, Sen-Quan Brouwer, Charlotte L. Korevaar, Erik W. Vapiwala, Neha Kang-Hsin Wang, Ken Deville, Curtiland Langendijk, Johannes A. Both, Stefan Aluwini, Shafak Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer |
title | Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer |
title_full | Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer |
title_fullStr | Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer |
title_full_unstemmed | Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer |
title_short | Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer |
title_sort | dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer |
topic | Technical Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407426/ https://www.ncbi.nlm.nih.gov/pubmed/37560512 http://dx.doi.org/10.1016/j.phro.2023.100474 |
work_keys_str_mv | AT fengsenquan doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer AT brouwercharlottel doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer AT korevaarerikw doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer AT vapiwalaneha doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer AT kanghsinwangken doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer AT devillecurtiland doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer AT langendijkjohannesa doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer AT bothstefan doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer AT aluwinishafak doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer |